Harel Liraz, Gefen Nir, Carmi Ofira, Orbach Pini, Einat Paz, Abitbol Guy
Nanodoc Biotechnology, 7 Sapir Str., Nes Ziona 7403630, Israel.
Dr. Paz Einat Biotechnology Projects & Consulting, 45a Moshe Levi Str., Nes Ziona 74207, Israel.
PLoS One. 2014 Dec 16;9(12):e115327. doi: 10.1371/journal.pone.0115327. eCollection 2014.
Small-interfering RNAs and microRNAs are small ∼21-22 nucleotide long RNAs capable of posttranscriptional suppression of gene expression. The synthetic siRNAs are especially designed to target pre-specified genes and are common molecular biology tools. The miRNAs are endogenous regulators of gene expression found in a wide variety of eukaryotes. miRNAs are currently utilized for diagnostics applications. Therapeutically, various miRNA-antagonizing tools are being explored and miRNAs are also utilized for cell-specific inhibition of the expression of gene therapy vectors harboring target sites for specific miRNAs. Here we show, for the first time, that siRNAs and miRNAs can be harnessed to induce gene expression. We designed special expression vectors in which target sites for artificial siRNAs or endogenous miRNAs are located between the transgene and an Upstream Inhibitory Region (UIR). We hypothesized that cleavage of the mRNA by siRNAs or miRNAs will separate the transgene from the UIR and the resulting uncapped mRNA will be capable of being translated. A UIR composed of seven open reading frames was found to be the most efficient inhibitor of the translation of the downstream transgene. We show that under such a configuration both artificial siRNAs and endogenous miRNAs were capable of inducing transgene expression. We show that using the diphtheria toxin A-chain gene, in combination with target sites for highly expressed miRNAs, specific induction of cell-death can be achieved, setting the stage for application to cancer therapy.
小干扰RNA和微小RNA是长度约为21 - 22个核苷酸的小RNA,能够在转录后抑制基因表达。合成的小干扰RNA是专门设计用于靶向预先指定基因的,是常见的分子生物学工具。微小RNA是在多种真核生物中发现的基因表达的内源性调节因子。微小RNA目前用于诊断应用。在治疗方面,正在探索各种微小RNA拮抗工具,并且微小RNA还用于细胞特异性抑制携带特定微小RNA靶位点的基因治疗载体的表达。在这里,我们首次表明小干扰RNA和微小RNA可用于诱导基因表达。我们设计了特殊的表达载体,其中人工小干扰RNA或内源性微小RNA的靶位点位于转基因和上游抑制区域(UIR)之间。我们假设小干扰RNA或微小RNA对mRNA的切割将使转基因与UIR分离,并且产生的无帽mRNA将能够被翻译。发现由七个开放阅读框组成的UIR是下游转基因翻译的最有效抑制剂。我们表明,在这种配置下,人工小干扰RNA和内源性微小RNA都能够诱导转基因表达。我们表明,使用白喉毒素A链基因,结合高表达微小RNA的靶位点,可以实现细胞死亡的特异性诱导,为癌症治疗的应用奠定基础。